Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
October 10, 2025 Off

Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress

By GlobeNewswire

– Complete B cell depletion, rapid reduction in autoantibodies and near-complete resolution of clinical symptoms in two of three refractory…

October 10, 2025 Off

Idorsia launches an offering of registered shares – to fund the company to overall profitability

By GlobeNewswire

Ad hoc announcement pursuant to Art. 53 LR NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, ITALY,…

October 10, 2025 Off

CERTIFIED Opens First Columbus Dispensary, Revives Local Landmark with Drive-Thru Cannabis Experience

By GlobeNewswire

Ohio-born cannabis brand brings personal story, community focus, and premium products to Silver Drive locationCOLUMBUS, Ohio, Oct. 09, 2025 (GLOBE…

October 10, 2025 Off

Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress

By GlobeNewswire

Preclinical data demonstrates proof-of-concept for EDIT-401 with ≥90% mean LDL-C reduction in non-human primates and mouse modelsCAMBRIDGE, Mass., Oct. 09,…

October 10, 2025 Off

Alkeus Pharmaceuticals Announces Presentation of Gildeuretinol Data at the American Academy of Ophthalmology (AAO) 2025 Annual Meeting, October 18-21 in Orlando

By GlobeNewswire

Results from the study of oral gildeuretinol in moderate Stargardt disease to be presented as late-breaker during Retina Subspecialty DayCAMBRIDGE,…

October 10, 2025 Off

Toro Neurovascular and Kaneka Announce Exclusive U.S. Distribution Partnership

By GlobeNewswire

Partnership to Enable U.S. Access to Toro’s Novel Neurovascular Catheter Portfolio Pending Regulatory Approval Toro Hero Toro Neurovascular’s catheter technology,…

October 10, 2025 Off

Optime Care Terminates Distributor Agreement for Korlym® (mifepristone)

By GlobeNewswire

ST. LOUIS, Oct. 09, 2025 (GLOBE NEWSWIRE) — Following 10+ years of service to Cushing’s syndrome patients, Optime Care, a…

October 10, 2025 Off

Akari Therapeutics Files Two New Patents for Immuno-Oncology Mode of Action for Novel ADC Platform Utilizing Spliceosome Modulating Payload PH1

By GlobeNewswire

BOSTON and LONDON, Oct. 09, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel…

October 9, 2025 Off

Apogee Therapeutics, Inc. Announces Pricing of $300 Million Underwritten Public Offering

By GlobeNewswire

SAN FRANCISCO and BOSTON, Oct. 08, 2025 (GLOBE NEWSWIRE) — Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing…

October 7, 2025 Off

Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements

By GlobeNewswire

WOODCLIFF LAKE, N.J., Oct. 06, 2025 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced…

Posts pagination

Previous 1 … 74 75 76 … 3,605 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine